Scancell Holdings plc (LON:SCLP - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 10.35 ($0.14) and traded as low as GBX 9 ($0.12). Scancell shares last traded at GBX 9.20 ($0.12), with a volume of 119,982 shares.
Scancell Price Performance
The firm's fifty day simple moving average is GBX 9.32 and its two-hundred day simple moving average is GBX 10.24. The firm has a market cap of £103.57 million, a PE ratio of -15.33 and a beta of 0.35. The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79.
Insider Activity
In other news, insider Martin Diggle acquired 44,944 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The shares were bought at an average price of GBX 9 ($0.12) per share, with a total value of £4,044.96 ($5,417.12). Company insiders own 4.96% of the company's stock.
Scancell Company Profile
(
Get Free Report)
Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.
Read More
Before you consider Scancell, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scancell wasn't on the list.
While Scancell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
